Class information for:
Level 1: BISPECIFIC ANTIBODIES//CATUMAXOMAB//TRIFUNCTIONAL ANTIBODY

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
10436 997 38.6 83%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
701 12232 RADIOIMMUNOTHERAPY//BISPECIFIC ANTIBODIES//EP CAM

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 BISPECIFIC ANTIBODIES Author keyword 162 51% 23% 229
2 CATUMAXOMAB Author keyword 42 72% 3% 33
3 TRIFUNCTIONAL ANTIBODY Author keyword 21 73% 2% 16
4 BISPECIFIC Author keyword 18 45% 3% 29
5 BISPECIFIC DIABODY Author keyword 15 67% 1% 14
6 BISPECIFIC MONOCLONAL ANTIBODIES Author keyword 10 57% 1% 12
7 BI SPECIFIC ANTIBODY Author keyword 9 83% 1% 5
8 QUADROMA Author keyword 8 70% 1% 7
9 CLIN COOPERAT GRP BISPECIF ANTIBODIES Address 8 100% 1% 5
10 BISPECIFIC MONOCLONAL ANTIBODY Author keyword 7 44% 1% 12

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 BISPECIFIC ANTIBODIES 162 51% 23% 229 Search BISPECIFIC+ANTIBODIES Search BISPECIFIC+ANTIBODIES
2 CATUMAXOMAB 42 72% 3% 33 Search CATUMAXOMAB Search CATUMAXOMAB
3 TRIFUNCTIONAL ANTIBODY 21 73% 2% 16 Search TRIFUNCTIONAL+ANTIBODY Search TRIFUNCTIONAL+ANTIBODY
4 BISPECIFIC 18 45% 3% 29 Search BISPECIFIC Search BISPECIFIC
5 BISPECIFIC DIABODY 15 67% 1% 14 Search BISPECIFIC+DIABODY Search BISPECIFIC+DIABODY
6 BISPECIFIC MONOCLONAL ANTIBODIES 10 57% 1% 12 Search BISPECIFIC+MONOCLONAL+ANTIBODIES Search BISPECIFIC+MONOCLONAL+ANTIBODIES
7 BI SPECIFIC ANTIBODY 9 83% 1% 5 Search BI+SPECIFIC+ANTIBODY Search BI+SPECIFIC+ANTIBODY
8 QUADROMA 8 70% 1% 7 Search QUADROMA Search QUADROMA
9 BISPECIFIC MONOCLONAL ANTIBODY 7 44% 1% 12 Search BISPECIFIC+MONOCLONAL+ANTIBODY Search BISPECIFIC+MONOCLONAL+ANTIBODY
10 REDIRECTED LYSIS 7 67% 1% 6 Search REDIRECTED+LYSIS Search REDIRECTED+LYSIS

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 HYBRID HYBRIDOMAS 127 80% 8% 78
2 BISPECIFIC ANTIBODIES 40 26% 14% 135
3 X ANTI CD3 ANTIBODY 27 92% 1% 11
4 TANDEM DIABODY 21 71% 2% 17
5 HYBRID ANTIBODIES 21 90% 1% 9
6 TARGETING C ERBB 2 20 100% 1% 9
7 CD19 X CD3 18 83% 1% 10
8 BITE ANTIBODY 18 89% 1% 8
9 X ANTI CD3 17 79% 1% 11
10 ANTI T3 15 82% 1% 9

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Bispecific T-cell engagers for cancer immunotherapy 2015 2 46 72%
Targeting T cells to tumor cells using bispecific antibodies 2013 31 45 58%
Bispecific antibodies for cancer therapy The light at the end of the tunnel? 2009 76 58 79%
Bispecific T-Cell Engaging Antibodies for Cancer Therapy 2009 120 20 55%
A revival of bispecific antibodies 2004 79 78 63%
A tale of two specificities: bispecific antibodies for therapeutic and diagnostic applications 2013 25 127 48%
Bispecific antibodies in cancer therapy 1999 104 38 61%
Blinatumomab: A historical perspective 2012 46 44 43%
Novel immunotherapies for hematologic malignancies 2015 4 157 19%
Dual targeting strategies with bispecific antibodies 2012 75 134 27%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 CLIN COOPERAT GRP BISPECIF ANTIBODIES 8 100% 0.5% 5
2 ADELE R DECOF CANC 5 60% 0.6% 6
3 RECOMBINANT ANTIBODY GRP D0500 4 75% 0.3% 3
4 CELL OURCE BIOMED 4 24% 1.4% 14
5 GASTROENTEROL TUMOR MICROENVIRONM 2 67% 0.2% 2
6 ABDOMINAL VASC TRANSPLANT SURG 2 26% 0.5% 5
7 IMMUNOTHER Y TREATMENT 1 38% 0.3% 3
8 RECOMBINANT ANTIBODY GRP 1 25% 0.4% 4
9 ANTIBODY TECHNOL 1 10% 1.0% 10
10 BIOSTAT COMMUNITY MED 1 40% 0.2% 2

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000153856 EP CAM//TROP2//EDRECOLOMAB
2 0.0000144952 SCFV//SINGLE CHAIN FV//PHAGE DISPLAY
3 0.0000081573 IMMUNOCYTOKINES//IMMUNOCYTOKINE//PHILOCHEM AG
4 0.0000081448 CD20//OFATUMUMAB//OBINUTUZUMAB
5 0.0000065918 T11TS//CD2//CD58
6 0.0000065647 CYTOKINE INDUCED KILLER CELLS//CIK CELLS//CYTOKINE INDUCED KILLER CELL
7 0.0000064187 PERITONEOVENOUS SHUNT//DENVER SHUNT//MALIGNANT ASCITES
8 0.0000061043 CHIMERIC ANTIGEN RECEPTOR//ADOPTIVE CELL THERAPY//CHIMERIC IMMUNE RECEPTOR
9 0.0000053500 IDIOTYPE//IDIOTYPE VACCINATION//CELL THER Y AREA
10 0.0000051567 TUMOR INFILTRATING LYMPHOCYTES//ADOPTIVE IMMUNOTHERAPY//AUTOLYMPHOCYTE THERAPY